AG
IPCI

Advisor Group’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Advisor Group’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,946
Closed -$13K – 5336
2018
Q2 		$13K Sell
2,946
-83
-3% -$377 ﹤0.01% 3966
2018
Q1 		$17K Sell
3,029
-916
-23% -$6.62K ﹤0.01% 3800
2017
Q4 		$31K Sell
3,945
-1,702
-30% -$15.5K ﹤0.01% 3421
2017
Q3 		$56K Buy
5,647
+906
+19% +$12.9K ﹤0.01% 2867
2017
Q2 		$100K Buy
4,741
+1,734
+58% +$36.3K ﹤0.01% 2310
2017
Q1 		$75K Buy
3,007
+1,378
+85% +$35.5K ﹤0.01% 2389
2016
Q4 		$47K Buy
1,629
+450
+38% +$12.6K ﹤0.01% 2664
2016
Q3 		$25K Buy
1,179
+653
+124% +$11.7K ﹤0.01% 3027
2016
Q2 		$7K Buy
+526
New +$9.58K ﹤0.01% 3662

Other funds holding IPCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
FANJ
Financial Architects (New Jersey) Marlton, New Jersey $663M AUM 15.53% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Advisor Group's IPCI Position: Q3 2018 in Review

Advisor Group sold out of Intellipharmaceuticals International Inc. (IPCI) in Q3 2018, closing a stake of 2,946 shares — an estimated $13K sold.

Advisor Group first reported a position in IPCI in Q2 2016 and held it in 9 quarters. The position peaked at $100K in Q2 2017. 10 funds tracked by Wall St. Rank hold IPCI as of Q3 2018.

  • Advisor Group reported no remaining Intellipharmaceuticals International Inc. position as of Q3 2018 after selling out during the quarter.
  • Advisor Group sold 2,946 Intellipharmaceuticals International Inc. shares in Q3 2018, an estimated $13K.
  • Advisor Group first reported a position in Intellipharmaceuticals International Inc. in Q2 2016 and held it in 9 quarters.
  • Advisor Group's Intellipharmaceuticals International Inc. position peaked at $100K in Q2 2017.
  • 10 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q3 2018.

Based on Advisor Group's 13F filing for Q3 2018, filed 14 Nov 2018.